We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+10.4%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$20.1B
AUM Growth
+$951M
Cap. Flow
-$224M
Cap. Flow %
-1.12%
Top 10 Hldgs %
32.44%
Holding
721
New
63
Increased
299
Reduced
261
Closed
36

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$55.1M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$46.1M
3
BABA icon
Alibaba
BABA
+$45M
4
NEE icon
NextEra Energy
NEE
+$40.9M
5
AMZN icon
Amazon
AMZN
+$38.3M

Top Sells

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$50.3M
2
META icon
Meta Platforms (Facebook)
META
+$44.2M
3
PG icon
Procter & Gamble
PG
+$34.1M
4
ZTS icon
Zoetis
ZTS
+$33.6M
5
CAH icon
Cardinal Health
CAH
+$32.2M

Sector Composition

Rank Sector Weight
1 Technology 34.01%
2 Healthcare 26.73%
3 Financials 11.13%
4 Consumer Discretionary 7.93%
5 Communication Services 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ITW icon
251
Illinois Tool Works
ITW
$84.1B
$12M 0.06%
48,856
-1,693
-3% -$422K
PHM icon
252
Pultegroup
PHM
$25.2B
$11.9M 0.06%
101,701
+46,084
+83% +$5.65M
LULU icon
253
lululemon athletica
LULU
$13.5B
$11.9M 0.06%
57,079
-86,819
-60% -$15.7M
MTZ icon
254
MasTec
MTZ
$22.7B
$11.8M 0.06%
54,398
-14,909
-22% -$3.13M
BURL icon
255
Burlington
BURL
$23.4B
$11.6M 0.06%
40,239
+36,083
+868% +$9.79M
IMNM icon
256
Immunome
IMNM
$2.62B
$11.6M 0.06%
539,882
-319,645
-37% -$5.61M
KD icon
257
Kyndryl
KD
$3.09B
$11.4M 0.06%
428,199
-144,570
-25% -$3.92M
APH icon
258
Amphenol
APH
$185B
$11.4M 0.06%
84,138
-23,404
-22% -$3.13M
PAYC icon
259
Paycom
PAYC
$7.88B
$10.8M 0.05%
67,677
-52,352
-44% -$9.28M
MET icon
260
MetLife
MET
$62.4B
$10.6M 0.05%
134,164
+57,279
+74% +$4.53M
CEG icon
261
Constellation Energy
CEG
$92.1B
$10.6M 0.05%
29,941
+5,146
+21% +$1.87M
TOST icon
262
Toast
TOST
$18.9B
$10.5M 0.05%
296,975
-305,225
-51% -$11M
HWM icon
263
Howmet Aerospace
HWM
$109B
$10.4M 0.05%
50,799
+1,488
+3% +$296K
HST icon
264
Host Hotels & Resorts
HST
$17.5B
$10.4M 0.05%
+585,236
New +$10.1M
DOV icon
265
Dover
DOV
$26.7B
$10.3M 0.05%
52,987
+2,860
+6% +$521K
OCUL icon
266
Ocular Therapeutix
OCUL
$1.83B
$10.2M 0.05%
+841,602
New +$10.2M
NRIX icon
267
Nurix Therapeutics
NRIX
$2.45B
$10.1M 0.05%
534,259
+271,875
+104% +$3.91M
APD icon
268
Air Products & Chemicals
APD
$65.5B
$9.96M 0.05%
40,334
-2,350
-6% -$596K
ALAB icon
269
Astera Labs
ALAB
$42.8B
$9.91M 0.05%
59,580
+15,880
+36% +$2.66M
CNTA
270
DELISTED
Centessa Pharmaceuticals
CNTA
$9.89M 0.05%
395,623
+52,416
+15% +$1.33M
AN icon
271
AutoNation
AN
$7.7B
$9.79M 0.05%
47,420
+22,530
+91% +$4.69M
COIN icon
272
Coinbase
COIN
$42.2B
$9.78M 0.05%
43,253
+15,703
+57% +$4.68M
EL icon
273
Estee Lauder
EL
$30.4B
$9.68M 0.05%
92,404
+53,438
+137% +$5.19M
WCN
274
Waste Connections
WCN
$43.6B
$9.65M 0.05%
54,956
-35,594
-39% -$6.15M
GMED icon
275
Globus Medical
GMED
$11.1B
$9.63M 0.05%
110,282
-17,647
-14% -$1.34M

Similar funds

Candriam SCA's Q4 2025 Portfolio in Review

As of Q4 2025, Candriam SCA held 721 positions worth $20.1B, up 5% from $19.1B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Candriam SCA's Q4 2025 filing shows 63 new, 299 increased, 261 reduced and 36 closed positions. Its largest new stake was Alibaba: 276,080 shares worth $40.5M. The largest sale was Equinix, an estimated $50.3M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q4 2025 buy was Alibaba: 276,080 shares worth $40.5M.
  • Candriam SCA added most to AbbVie in Q4 2025, an estimated $55.1M increase.
  • Candriam SCA's biggest Q4 2025 reduction was Equinix, cutting an estimated $50.3M.
  • Candriam SCA fully exited Universal Display in Q4 2025, selling an estimated $27.1M.
  • Candriam SCA's ten largest holdings make up 32% of its $20.1B portfolio in Q4 2025.
  • Candriam SCA opened 63 new positions and closed 36 in Q4 2025.
  • Candriam SCA's portfolio value rose 5% quarter-over-quarter to $20.1B.

Based on Candriam SCA's 13F filing for Q4 2025, filed 13 Feb 2026.